Immunologic constant of rejection signature is prognostic in soft-tissue sarcoma and refines the CINSARC signature | Journal for ImmunoTherapy of Cancer

Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Browse by collection

Archive

Authors

About
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

PDF +
Supplementary
Material

Immunotherapy biomarkers

Original research

Immunologic constant of rejection signature is prognostic in soft-tissue sarcoma and refines the CINSARC signature

Online download statistics by month:

Online download statistics by month: January 2022 to August 2024

	Abstract	Full	Pdf
Jan 2022	265	279	92
Feb 2022	100	102	36
Mar 2022	127	136	37
Apr 2022	100	105	29
May 2022	93	94	29
Jun 2022	107	110	27
Jul 2022	106	110	19
Aug 2022	142	145	14
Sep 2022	131	139	41
Oct 2022	109	115	26
Nov 2022	100	100	24
Dec 2022	70	70	14
Jan 2023	59	59	20
Feb 2023	64	64	18
Mar 2023	44	46	37
Apr 2023	36	38	28
May 2023	46	54	33
Jun 2023	38	38	23
Jul 2023	37	39	26
Aug 2023	42	42	18
Sep 2023	28	28	11
Oct 2023	22	23	6
Nov 2023	24	24	4
Dec 2023	33	34	6
Jan 2024	38	38	16
Feb 2024	33	33	12
Mar 2024	31	33	38
Apr 2024	23	23	38
May 2024	25	27	20
Jun 2024	54	53	19
Jul 2024	48	50	29
Aug 2024	46	45	16
Total	2221	2296	806